)
)
Revance Therapeutics Investor Relations Material
Latest events
Q2 2024
Revance Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Revance Therapeutics Inc
Access all reports
Revance Therapeutics Inc. is a biotechnology company focused on developing and commercializing innovative aesthetic and therapeutic treatments. The company’s portfolio includes Daxxify, a long-lasting botulinum toxin for wrinkle reduction, and other injectable products for aesthetic enhancements. Revance also develops treatments targeting neurological and musculoskeletal disorders. Revance Therapeutics is headquartered in Nashville, Tennessee, and its shares are listed on the NASDAQ.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
RVNC
Country
🇺🇸 United States